CDMO PLATFORM

Agile and flexible CDMO services tailored to your requirements

CAPABILITIES

World-class biologics contract development and manufacturing

We are a global CDMO with 14+ years of patient-centric experience in the development and manufacture of biopharmaceuticals. We offer a personalized service and our commitment to respond with agility to meet your exact manufacturing needs and expedite time to clinical stages and market.

Single-use technology and flexible scales

We have streamlined manufacturing processes for high operational efficiency and reduced time-to-market

Double-source manufacturing facilities

Our state-of-the-art production sites in Europe and South America have identical manufacturing configurations for seamless backup and adaptability to demand

Commercial stage CDMO

We have years of expertise bringing biologics to the market ensuring high quality medicines timely reach patients worldwide.

Our cutting-edge scalable systems include:
  • Single-use lab-scale bioreactors: 2L, 5L, 10L and 50L
  • Single-use GMP bioreactors: 200L, 1000L, 2000L and 4000L

SERVICES

End-to-end CDMO solutions for efficient clinical and market supply

Our CDMO services are fully integrated, agile and flexible: from cell line development to bulk drug substance. In all our processes we apply high-quality, innovative technologies and on site strong analytical capabilities at our modern facilities to help accelerate your programs and facilitate early market entry.

EXPERTISE

Customized CDMO solutions for a broad variety of biopharmaceuticals

Our expertise is in the field of biopharmaceutical development and manufacturing, combined with strong in-house analytical capabilities. Our core competencies are applied to antibody formats and other complex proteins like enzymes, fusion proteins and other biologics. We have a proven track record in delivery of high value, high profile biologic projects.

Antibodies

Monoclonal
Chimeric
Bispecific

Vaccines

Virus vector-based vaccines
Adenovirus vaccines
Vaccinia vector-based

Fusion
proteins

Fc Fusions
Multispecific proteins

CASE STUDIES

From clinical to commercial batches, we pay close attention to detail in every project

AstraZeneca COVID-19 Adenoviral vaccine manufacturing

We were AstraZeneca’s chosen manufacturing partner for COVID-19 vaccine in Latin America and EU. The contract was set up in only 3 months with optimal results, including transfer, certification, expansion and optimization.

  • Optimal manufacturing deliveries
  • Full validation of all processes and technology in record time
  • Expansion of capacity and process improvement
  • Continuous quality certifications
  • +200.000.000 doses delivered
Bevacizumab manufacturing

We have run uninterrupted manufacturing campaigns since 2019 of our biosimilar bevacizumab.

  • Manufacturing in Genhelix site, Spain
  • Manufactured over 400kgs of Bevacizumab only in 2022
  • Global launch with +900,000 vials supplied WW over a 12-month period
  • Product approved by FDA, EMA and PMDA

Want to learn all about our CDMO platform? Download the brochure

Contact us